HL
Harding Loevner Portfolio holdings
AUM
$13.6B
1-Year Est. Return
20.3%
1 Year Est. Return
+20.3%
AUM
$13.6B
AUM Growth
-$1.23B
(-8.3%)
Holding
73
Top Buys
| 1 | +$321M | |
| 2 | +$279M | |
| 3 | +$84.4M | |
| 4 |
Elevance Health
ELV
|
+$79.6M |
| 5 |
Ryanair
RYAAY
|
+$57.6M |
Top Sells
| 1 | +$219M | |
| 2 | +$205M | |
| 3 | +$147M | |
| 4 |
Applied Materials
AMAT
|
+$130M |
| 5 |
TSMC
TSM
|
+$127M |
Sector Composition
| 1 | Technology | 30.68% |
| 2 | Financials | 16.56% |
| 3 | Communication Services | 10.48% |
| 4 | Healthcare | 9.96% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$108B
| $179M | 1.31% |
455,988
-255,623
|
|
||
27
Progressive
PGR
$134B
| $171M | 1.25% |
691,378
+341,824
|
|
||
28
Banco Bilbao Vizcaya Argentaria
BBVA
$124B
| $169M | 1.24% |
8,758,673
-110,222
|
|
||
29
Haleon
HLN
$43.6B
| $161M | 1.18% |
17,909,401
-4,641,640
|
|
||
30
Manulife Financial
MFC
$59.2B
| $158M | 1.16% |
5,077,216
-1,060,716
|
|
||
31
Amphenol
APH
$170B
| $155M | 1.14% |
1,251,914
-191,563
|
|
||
32
Broadcom
AVGO
$1.82T
| $149M | 1.09% |
451,298
-313,687
|
|
||
33
Deere & Co
DE
$127B
| $148M | 1.09% |
324,719
-129,749
|
|
||
34
Tradeweb Markets
TW
$22.8B
| $145M | 1.06% |
1,303,676
-479,140
|
|
||
35
Rio Tinto
RIO
$117B
| $125M | 0.91% |
1,887,696
-16,253
|
|
||
36
Synopsys
SNPS
$81.4B
| $119M | 0.87% |
240,194
-41,370
|
|
||
37
Accenture
ACN
$160B
| $116M | 0.85% |
470,517
+41,129
|
|
||
38
Genmab
GMAB
$19.3B
| $107M | 0.78% |
3,484,487
+561,048
|
|
||
39
Adobe
ADBE
$135B
| $106M | 0.78% |
301,169
-58,897
|
|
||
40
HEICO Corp
HEI
$43.1B
| $106M | 0.78% |
328,553
-113,597
|
|
||
41
AbbVie
ABBV
$398B
| $99.7M | 0.73% |
430,494
-161,894
|
|
||
42
Telkom Indonesia
TLK
$21.8B
| $92.7M | 0.68% |
4,925,278
-89,824
|
|
||
43
CoStar Group
CSGP
$28.8B
| $91.4M | 0.67% |
1,083,322
-383,758
|
|
||
44
ServiceNow
NOW
$171B
| $88.4M | 0.65% |
96,013
-34,562
|
|
||
45
Danaher
DHR
$158B
| $82.4M | 0.6% |
415,656
-155,178
|
|
||
46
Thermo Fisher Scientific
TMO
$220B
| $81.8M | 0.6% |
168,576
-60,955
|
|
||
47
Ametek
AME
$45B
| $80.8M | 0.59% |
429,956
-147,967
|
|
||
48
Novartis
NVS
$247B
| $80.8M | 0.59% |
629,958
+316,431
|
|
||
|
49
Elevance Health
ELV
$73.3B
| $79.6M | 0.58% |
+246,365
|
|
||
50
Johnson & Johnson
JNJ
$495B
| $78.8M | 0.58% |
424,760
-154,422
|
|